All In MedTech

Device Trial Radar · NCT00882661

SECURE®-C Cervical Artificial Disc Clinical Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study

A Prospective Randomized Clinical Investigation of the SECURE-C Cervical Artificial Disc: A Pivotal Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study

Last checked: Nov 20, 2026Latest source record: Jun 9, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingTitle says "pivotal". Randomized with 380 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

380

Actual

Start

Jul 2005

Primary completion

Apr 2010

Study completion Feb 2017

Sponsor

Lead sponsor
Globus Medical IncPublic (GMED)
Sponsor type
Industry
First posted
Apr 16, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the pivotal IDE clinical study was to evaluate the safety and effectiveness of the SECURE®-C Cervical Artificial Disc for the treatment of symptomatic cervical disc disease at one level between C3 and C7, compared to anterior cervical discectomy and fusion. The purpose of the Postmarket Approval Study is to evaluate the long-term safety and efficacy associated with the use of the SECURE-C Cervical Artificial Disc

Conditions

  • Symptomatic Cervical Disc Disease

Interventions

  • SECURE-C Cervical Artificial DiscDevice

    Treatment of symptomatic cervical disc disease with the SECURE-C Cervical Artificial Disc

  • ASSURE Cervical plate and an allograft interbody spacerDevice

    Treatment of symptomatic cervical disc disease utilizing an instrumented anterior discectomy and interbody fusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Individual Patient Overall SuccessTime frame: 24 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.